Cargando…

Radiosensitization approaches for HPV‐positive and HPV‐negative head and neck squamous carcinomas

Radiotherapy is one of the most used treatment approaches for head and neck squamous cell carcinoma (HNSCC). Targeted inhibition of DNA repair machinery has the potential to improve treatment response by tailoring treatment to cancer cells lacking specific DNA repair pathways. Human papillomavirus (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dok, Rüveyda, Bamps, Marieke, Glorieux, Mary, Zhao, Peihua, Sablina, Anna, Nuyts, Sandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2019
Materias:	Cancer Therapy and Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973261/ https://www.ncbi.nlm.nih.gov/pubmed/31283004 http://dx.doi.org/10.1002/ijc.32558

Ejemplares similares

Effect of ATR Inhibition in RT Response of HPV-Negative and HPV-Positive Head and Neck Cancers
por: Dok, Rüveyda, et al.
Publicado: (2021)

The DNA Damage Response Is Differentially Involved in HPV-Positive and HPV-Negative Radioresistant Head and Neck Squamous Cell Carcinoma
por: Bamps, Marieke, et al.
Publicado: (2021)

Dual role for p16 in the metastasis process of HPV positive head and neck cancers
por: Dok, Rüveyda, et al.
Publicado: (2017)

Hypoxia and Its Influence on Radiotherapy Response of HPV-Positive and HPV-Negative Head and Neck Cancer
por: Wegge, Marilyn, et al.
Publicado: (2021)

Low-Level Laser Therapy Stimulates Proliferation in Head and Neck Squamous Cell Carcinoma Cells
por: Bamps, Marieke, et al.
Publicado: (2018)

HPV Positive Head and Neck Cancers: Molecular Pathogenesis and Evolving Treatment Strategies
por: Dok, Rüveyda, et al.
Publicado: (2016)

Novel DNA targeted therapies for head and neck cancers: clinical potential and biomarkers
por: Glorieux, Mary, et al.
Publicado: (2017)

The influence of PI3K inhibition on the radiotherapy response of head and neck cancer cells
por: Glorieux, Mary, et al.
Publicado: (2020)

Current trends in the etiology and diagnosis of HPV-related head and neck cancers
por: Chai, Ryan C, et al.
Publicado: (2015)

Human papillomavirus‐based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trial
por: Gottschlich, Anna, et al.
Publicado: (2022)

Effectiveness of the AS04‐adjuvanted HPV‐16/18 vaccine in reducing oropharyngeal HPV infections in young females—Results from a community‐randomized trial
por: Lehtinen, Matti, et al.
Publicado: (2019)

Prevalence of high‐risk human papillomavirus after HPV‐vaccination in Denmark
por: Lynge, Elsebeth, et al.
Publicado: (2020)

Now or later: Health impacts of delaying single‐dose HPV vaccine implementation in a high‐burden setting
por: Burger, Emily A., et al.
Publicado: (2022)

Joint effect of tobacco, alcohol, and oral HPV infection on head and neck cancer risk in the French West Indies
por: Auguste, Aviane, et al.
Publicado: (2020)

Awareness and knowledge of Human Papillomavirus (HPV), HPV‐related cancers, and HPV vaccines in an uninsured adult clinic population
por: Radecki Breitkopf, Carmen, et al.
Publicado: (2016)

Initial results of population based cervical cancer screening program using HPV testing in one million Turkish women
por: Gultekin, Murat, et al.
Publicado: (2017)

Nuclear p16INK4a expression predicts enhanced radiation response in head and neck cancers
por: Dok, Rüveyda, et al.
Publicado: (2016)

Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology‐screened referral population
por: Leeman, Annemiek, et al.
Publicado: (2018)

Clinical validation of p16/Ki‐67 dual‐stained cytology triage of HPV‐positive women: Results from the IMPACT trial
por: Wright, Thomas C., et al.
Publicado: (2021)

Cervical cancer risk in HPV‐positive women after a negative FAM19A4/mir124‐2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow‐up
por: De Strooper, Lise M.A., et al.
Publicado: (2018)

A systematic review of the HPV‐attributable fraction of oropharyngeal squamous cell carcinomas in Germany
por: Reuschenbach, Miriam, et al.
Publicado: (2019)

Telomere length in cervical exfoliated cells, interaction with HPV genotype, and cervical cancer occurrence among high‐risk HPV‐positive women
por: Chen, Xiaojun, et al.
Publicado: (2019)

The potential population‐based impact of an HPV vaccination intervention in Colorado
por: Cataldi, Jessica R., et al.
Publicado: (2019)

The radiobiology of HPV-positive and HPV-negative head and neck squamous cell carcinoma
por: Zhou, Chumin, et al.
Publicado: (2020)

Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial
por: Ferris, Robert L, et al.
Publicado: (2021)

Missed opportunities for concomitant HPV vaccination among childhood cancer survivors
por: Ramsay, Joemy M., et al.
Publicado: (2022)

Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance
por: Hanna, Glenn J., et al.
Publicado: (2023)

Targeting DNA Double-Strand Break Repair Enhances Radiosensitivity of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma to Photons and Protons
por: Vitti, Eirini Terpsi, et al.
Publicado: (2020)

Intrinsic Radiosensitivity Is Not the Determining Factor in Treatment Response Differences between HPV Negative and HPV Positive Head and Neck Cancers
por: Reid, Paul, et al.
Publicado: (2020)

The precision prevention and therapy of HPV‐related cervical cancer: new concepts and clinical implications
por: Hu, Zheng, et al.
Publicado: (2018)

Use of 3D Spheroid Models for the Assessment of RT Response in Head and Neck Cancer
por: Wegge, Marilyn, et al.
Publicado: (2023)

Mitochondrial DNA copy number is associated with risk of head and neck squamous cell carcinoma in Chinese population
por: Wang, Lihua, et al.
Publicado: (2018)

Noncanonical HPV carcinogenesis drives radiosensitization of head and neck tumors
por: Schrank, Travis P., et al.
Publicado: (2023)

The distribution and pathogenic risk of non‐9‐valent vaccine covered HPV subtypes in cervical lesions
por: Ma, Mingjun, et al.
Publicado: (2022)

At what age should the Uyghur minority initiate cervical cancer screening if screened using careHPV
por: Abulizi, Guzhalinuer, et al.
Publicado: (2021)

Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo
por: Liu, Xuejiao, et al.
Publicado: (2019)

Prognostic Significance of Glutathione Peroxidase Levels (GPx1) in Head and Neck Cancers
por: Dequanter, Didier, et al.
Publicado: (2017)

Cervical cancer screening in a low‐resource setting: a pilot study on an HPV‐based screen‐and‐treat approach
por: Kunckler, Margot, et al.
Publicado: (2017)

HPV‐vaccination and cancer cervical screening in 53 WHO European Countries: An update on prevention programs according to income level
por: Altobelli, Emma, et al.
Publicado: (2019)

Incidence trends of squamous cell carcinoma of the head and neck (SCCHN) in the aging population––A SEER‐based analysis from 2000 to 2016
por: Taylor, Melissa A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h9h46pf9ruj2kmcsk58irv9h0j